The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study

BACKGROUND: Maintenance treatment following efficient chemotherapy can improve the treatment outcomes of patients with metastatic breast cancer (MBC). However, there are no studies for identifying the prognostic factors for patients who could benefit from capecitabine maintenance. Therefore, this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Can, Yang, Jianbo, Xie, Ning, Tang, Yu, Zhou, Haoyu, Hu, Zhe-Yu, Ouyang, Quchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511179/
https://www.ncbi.nlm.nih.gov/pubmed/36172110
http://dx.doi.org/10.21037/atm-22-3828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511179/
https://www.ncbi.nlm.nih.gov/pubmed/36172110
http://dx.doi.org/10.21037/atm-22-3828

Ejemplares similares